Katherine D. Cummins
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 2
- Oncology top 10%
- CAR-T cell therapy research 10
-
- Virus-based gene therapy research 3
-
- CRISPR and Genetic Engineering 4
- Viral Infectious Diseases and Gene Expression in Insects 3
- RNA Interference and Gene Delivery 2
-
- Acute Lymphoblastic Leukemia research 2
- Co-authors
- Saar GillSelene Nuñez-CruzAdrian CantuJohn LeferovichSaba GhassemiMarilia Rita PinzoneMichael C. MiloneJoseph S. Durgin
- Cited by
- HematologyOncologyImmunology
- Partner nations
- United StatesAustraliaIsrael
In The Last Decade
Katherine D. Cummins
16 papers receiving 589 citations
Hit Papers
Peers
Comparison fields: 5 of 38
- Hematology 175
- Oncology 408
- Immunology 123
- Genetics 147
- Molecular Biology 281
Countries citing papers authored by Katherine D. Cummins
This map shows the geographic impact of Katherine D. Cummins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine D. Cummins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine D. Cummins more than expected).
Fields of papers citing papers by Katherine D. Cummins
This network shows the impact of papers produced by Katherine D. Cummins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine D. Cummins. The network helps show where Katherine D. Cummins may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Katherine D. Cummins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 1 | |
| 5 | Rapid manufacturing of non-activated potent CAR T cellsbreakdown → | 2022 | 184 |
| 6 | 2022 | 1 | |
| 7 | 2020 | 32 | |
| 8 | 2020 | 4 | |
| 9 | 2019 | 52 | |
| 10 | 2019 | 3 | |
| 11 | 2019 | 1 | |
| 12 | 2018 | 50 | |
| 13 | 2017 | 92 | |
| 14 | 2017 | 124 | |
| 15 | 2017 | 28 | |
| 16 | 2015 | 11 | |
| 17 | 2015 | 1 | |
| 18 | 2014 | 6 |
About Katherine D. Cummins
Katherine D. Cummins is a scholar working on Oncology, Hematology and Molecular Biology, having authored 18 papers that have together received 595 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), CRISPR and Genetic Engineering (4 papers), Virus-based gene therapy research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Acute Myeloid Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Hematology (175 citations), Oncology (408 citations) and Immunology (123 citations). Katherine D. Cummins has collaborated with scholars based in United States, Australia and Israel. Frequent co-authors include Saar Gill, Selene Nuñez-Cruz, Adrian Cantu, John Leferovich, Saba Ghassemi, Marilia Rita Pinzone, Michael C. Milone, Joseph S. Durgin, Jai Patel and Frederic D. Bushman. Their work appears in journals such as Journal of Clinical Investigation, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.